Early research (Phase 1)Ended earlyNCT05904236What this trial is testingSafety and Tolerability of Intravenous Administration of ICVB-1042Who this might be right forPatients With Advanced Solid Tumors IconOVir Bio 17
Early research (Phase 1)Ended earlyNCT05573035What this trial is testingInvestigate LYL845 in Adults With Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerColorectal Cancer Lyell Immunopharma, Inc. 39
Large-scale testing (Phase 3)Ended earlyNCT00416910What this trial is testingCombination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 83
Testing effectiveness (Phase 2)Study completedNCT01828021What this trial is testingPhase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast CancerWho this might be right forBreast Cancer MacroGenics 25
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Very early researchUnknownNCT05812677What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial CancerWho this might be right forCervical CancerEndometrial CancerAdvanced Cancer Shanghai Yunying Medical Technology 20
Early research (Phase 1)Study completedNCT01314105What this trial is testingBIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal CancerWho this might be right forOvarian NeoplasmsPeritoneal Neoplasms Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935361What this trial is testingGuadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or RelapsedWho this might be right forChronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes University of Southern California 33
Early research (Phase 1)Study completedNCT03338972What this trial is testingImmunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple MyelomaWho this might be right forRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00132028What this trial is testingVorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's LymphomaWho this might be right forAdult Favorable Prognosis Hodgkin LymphomaAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin Lymphoma+5 more National Cancer Institute (NCI) 27
Large-scale testing (Phase 3)Study completedNCT05169801What this trial is testingTo Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLCWho this might be right forNon-small Cell Lung Cancer(NSCLC) Jiangsu HengRui Medicine Co., Ltd. 520
Testing effectiveness (Phase 2)Study completedNCT01915498What this trial is testingPhase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) MutationWho this might be right forHematologic Neoplasms Celgene 345
Early research (Phase 1)Looking for participantsNCT06999187What this trial is testingDR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasWho this might be right forTriple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more Dren Bio 96
Early research (Phase 1)UnknownNCT04739293What this trial is testingStudy of ON 123300 in Patients With Advanced CancerWho this might be right forSolid Tumors, Adult Traws Pharma, Inc. 36
Early research (Phase 1)Looking for participantsNCT06487624What this trial is testingAn Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced TumorsWho this might be right forAdvanced Solid TumorRefractory Hodgkin Lymphoma FBD Biologics Limited 50
Early research (Phase 1)Looking for participantsNCT06730659What this trial is testingA Clinical Study of CHT101 in CD70-Positive Advanced Solid TumorsWho this might be right forRelapsed / Refractory Solid Tumor Tianjin Medical University Cancer Institute and Hospital 36
Early research (Phase 1)Looking for participantsNCT07444268What this trial is testingHow [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood CancersWho this might be right forAdvanced Hematologic Malignancies Sumitomo Pharma America, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Early research (Phase 1)Looking for participantsNCT05768932What this trial is testingBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdvanced Solid TumorTNBC - Triple-Negative Breast CancerGastric Cancer+1 more SillaJen, Inc. 260